{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:57:15Z","timestamp":1780678635262,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RfPB PB-PG-1217-20034"],"award-info":[{"award-number":["RfPB PB-PG-1217-20034"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.euf.2021.12.012","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T22:46:53Z","timestamp":1641941213000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment and Treatment of Nocturia in Neurological Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus"],"prefix":"10.1016","volume":"8","author":[{"given":"Nadine A.M.","family":"van Merode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Cotterill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson L.","family":"Huntley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.12.012_b0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.23917","article-title":"International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function","volume":"38","author":"Hashim","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0010","article-title":"Nocturia is associated with slipping and falling","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2021.12.012_b0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2010.09763.x","article-title":"Nocturia as a manifestation of systemic disease","volume":"107","author":"Gulur","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.12.012_b0020","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.eururo.2012.07.004","article-title":"A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management\u2014a systematic review and meta-analysis","volume":"62","author":"Cornu","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0025","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2020.02.007","article-title":"Nocturia and nocturnal polyuria in neurological patients: from epidemiology to treatment. A systematic review of the literature","volume":"6","author":"Haddad","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2021.12.012_b0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/nau.23921","article-title":"Desmopressin for treating nocturia in patients with multiple sclerosis: a systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"Phe","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2017.06.010","article-title":"Medical treatment of nocturia in men with lower urinary tract symptoms: systematic review by the European Association of Urology guidelines panel for male lower urinary tract symptoms","volume":"72","author":"Sakalis","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0040","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.urology.2015.02.043","article-title":"Nocturia: current levels of evidence and recommendations from the International Consultation on Male Lower Urinary Tract Symptoms","volume":"85","author":"Marshall","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.012_b0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.euf.2021.12.012_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1464-410X.90.s3.3.x","article-title":"The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society","volume":"90","author":"Van Kerrebroeck","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.12.012_b0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bju.12753","article-title":"Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia and nocturnal polyuria: a systematic review","volume":"115","author":"Hofmeester","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.12.012_b0060","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2021.12.012_b0065","first-page":"655","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"McMillan","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.euf.2021.12.012_b0070","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/nau.24469","article-title":"Assessment of patients with lower urinary tract symptoms where an undiagnosed neurological disease is suspected: a report from an International Continence Society consensus working group","volume":"39","author":"Roy","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12883-018-1114-4","article-title":"Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of nocturia in adults with multiple sclerosis (MeNiMS)","volume":"18","author":"Drake","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.euf.2021.12.012_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116625","article-title":"Extended release levodopa at bedtime as a treatment for nocturiain Parkinson\u2019s disease: an open label study","volume":"410","author":"Brusa","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euf.2021.12.012_b0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson\u2019s disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.euf.2021.12.012_b0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0000000000000281","article-title":"Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson disease patients","volume":"41","author":"Kitta","year":"2018","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.euf.2021.12.012_b0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parkreldis.2003.08.001","article-title":"Effects of pergolide on nocturia in Parkinson\u2019s disease: three female cases selected from over 400 patients","volume":"10","author":"Kuno","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2021.12.012_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2021.12.012_b0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/nau.22365","article-title":"Nocturia and overnight polysomnography in Parkinson disease","volume":"32","author":"Vaughan","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson\u2019s disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euf.2021.12.012_b0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/nau.22868","article-title":"Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results","volume":"36","author":"Canbaz Kabay","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0120","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/1352458511414040","article-title":"Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial","volume":"17","author":"Gobbi","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2021.12.012_b0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/1352458510378020","article-title":"Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis","volume":"16","author":"Kavia","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.euf.2021.12.012_b0130","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/nau.20941","article-title":"Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis","volume":"29","author":"L\u00facio","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.urology.2003.10.019","article-title":"Development and validation of a quality-of-life measure for men with nocturia","volume":"63","author":"Abraham","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.012_b0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/nau.23939","article-title":"International Continence Society consensus on the diagnosis and treatment of nocturia","volume":"38","author":"Everaert","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 6","key":"10.1016\/j.euf.2021.12.012_b0150","first-page":"S25","article-title":"Neurological lower urinary tract dysfunction essential terminology","volume":"37","author":"Gajewski","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0155","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/nau.23397","article-title":"An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)","volume":"37","author":"Gajewski","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/nau.23027","article-title":"Neurogenic lower urinary tract dysfunction: clinical management recommendations of the Neurologic Incontinence Committee of the fifth International Consultation on Incontinence 2013","volume":"35","author":"Drake","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/nau.23289","article-title":"Neurogenic bowel dysfunction: clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013","volume":"37","author":"Cotterill","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1464-410X.2012.11749.x","article-title":"The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy","volume":"111","author":"Weiss","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.12.012_b0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.euf.2021.12.012_b0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/nau.24552","article-title":"Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson\u2019s disease: a double-blind, randomized placebo-controlled trial (Parkinson\u2019s Disease Overactive Bladder Mirabegron, PaDoMi study)","volume":"40","author":"Cho","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","article-title":"The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"87","author":"Kabay","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.012_b0190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/nau.24595","article-title":"Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson\u2019s disease: a randomized clinical trial","volume":"40","author":"Araujo","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0195","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.juro.2013.12.051","article-title":"Long-term followup of children with nocturnal enuresis: increased frequency of nocturia in adulthood","volume":"191","author":"Goessaert","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/nau.22912","article-title":"Risk factors and functional abnormalities associated with adult onset secondary nocturnal enuresis in women","volume":"36","author":"Madhu","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/bjp.bp.111.095737","article-title":"Nocturnal enuresis with antipsychotic medication","volume":"200","author":"Barnes","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.euf.2021.12.012_b0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/nau.22219","article-title":"Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011","volume":"31","author":"Weiss","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euf.2021.12.012_b0215","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.juro.2013.10.100","article-title":"The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses","volume":"191","author":"Hofmeester","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrurol.2010.147","article-title":"Management of overactive bladder","volume":"7","author":"Gulur","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0225","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.purol.2015.02.004","article-title":"La polyurie nocturne est-elle plus fr\u00e9quente chez les patients parkinsoniens? [Is nocturnal polyuria more frequent among patients with Parkinson\u2019s disease?]","volume":"25","author":"Romain","year":"2015","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2021.12.012_b0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mdc3.12279","article-title":"Nocturia in patients with Parkinson\u2019s disease","volume":"3","author":"Smith","year":"2015","journal-title":"Mov Disord Clin Pract"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:37:02Z","timestamp":1778881022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2405456921003230"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.12.012","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment and Treatment of Nocturia in Neurological Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}